GO:2000758 positive regulation of peptidyl-lysine acetylation: Regulatory Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:2000758 describes any process that activates or increases the frequency, rate or extent of peptidyl-lysine acetylation, a key post-translational modification.
• Lysine acetylation is dynamically regulated by acetyltransferases (writers) and deacetylases (erasers), and its positive regulation can occur at multiple levels.
• In bacteria such as Escherichia coli, lysine acetylation is linked to antibiotic resistance, highlighting its broad biological significance.
• Key genes involved include acetyltransferases (e.g., GNAT family), deacetylases, and metabolic enzymes that influence acetyl-CoA levels.
• Dysregulation of lysine acetylation is implicated in cancer, neurodegeneration, and metabolic disorders, making it a therapeutic target.
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) enable precise dissection of positive regulation mechanisms.
Description
Post-translational modifications (PTMs) are essential for expanding proteome diversity and regulating protein function. Among these, lysine acetylation is a reversible modification that neutralizes the positive charge of lysine residues, affecting protein stability, interactions, and enzymatic activity. The Gene Ontology (GO) term GO:2000758, positive regulation of peptidyl-lysine acetylation, captures the processes that enhance this modification. Understanding this term is crucial because acetylation is not merely a static mark but a dynamic event controlled by a network of enzymes and metabolic cues. In recent years, lysine acetylation has emerged as a central regulator of diverse cellular processes, from transcription to metabolism. In bacteria, for example, acetylation of metabolic enzymes can modulate antibiotic resistance, underscoring its evolutionary conservation and clinical relevance. Thus, researchers studying this term aim to uncover how cells actively promote acetylation and how this regulation impacts health and disease.
positive regulation of peptidyl-lysine acetylation At A Glance
| GO ID | GO:2000758 |
|---|---|
| GO term | positive regulation of peptidyl-lysine acetylation |
| Ontology | biological_process |
| Synonym | None |
| Major function | Upregulation of lysine acetylation on target proteins |
| Related processes | Regulation of acetyltransferase activity, deacetylase inhibition, acetyl-CoA metabolism |
| Cellular context | Nucleus, cytoplasm, mitochondria |
| Disease relevance | Cancer, neurodegeneration, metabolic disorders, antibiotic resistance |
What Is GO:2000758?
According to the Gene Ontology, GO:2000758 (positive regulation of peptidyl-lysine acetylation) is defined as any process that activates or increases the frequency, rate or extent of peptidyl-lysine acetylation. In simpler terms, it encompasses all molecular events that lead to more acetylation marks being added to lysine residues on proteins, whether by activating acetyltransferases, inhibiting deacetylases, or increasing the availability of acetyl-CoA.
Why Is positive regulation of peptidyl-lysine acetylation Important in Cell Biology?
Positive regulation of peptidyl-lysine acetylation is fundamental to cellular adaptation and signaling. It controls gene expression by modifying histones, regulates enzyme activity in metabolic pathways, and influences protein-protein interactions. In pathogenic bacteria, acetylation dynamics contribute to antibiotic resistance, a major public health threat. Therefore, deciphering the mechanisms that positively regulate acetylation can reveal new therapeutic targets and biomarkers.
• Controls chromatin structure and gene transcription via histone acetylation.
• Regulates metabolic enzyme activity and cellular metabolism.
• Modulates protein stability and interactions.
• Plays a role in bacterial antibiotic resistance mechanisms.
• Implicated in cancer development and progression.
• Associated with neurodegenerative diseases.
• Influences immune cell function and inflammation.
• Provides targets for epigenetic therapies.
• Essential for stress responses and cellular homeostasis.
• Key area for drug discovery and precision medicine.
What Happens During positive regulation of peptidyl-lysine acetylation?
Activation of Acetyltransferases
In simple terms: Enzymes that add acetyl groups are turned on.
Positive regulation often begins with the activation of lysine acetyltransferases (KATs), such as the GNAT family enzymes. These enzymes transfer acetyl groups from acetyl-CoA to lysine residues on target proteins. Their activity can be enhanced by phosphorylation, allosteric binding, or increased expression.
Inhibition of Deacetylases
In simple terms: Enzymes that remove acetyl groups are turned off.
Another key mechanism is the suppression of deacetylases (HDACs and sirtuins). When deacetylase activity is reduced, the net acetylation level increases. This can occur through post-translational modifications, protein-protein interactions, or changes in cellular localization.
Increased Acetyl-CoA Availability
In simple terms: More raw material for acetylation is provided.
Acetyl-CoA is the acetyl group donor for acetylation reactions. Positive regulation can be achieved by boosting acetyl-CoA production through metabolic pathways such as glycolysis and fatty acid oxidation, or by inhibiting its consumption.
Recruitment of Acetyltransferase Complexes
In simple terms: The acetylation machinery is brought to the right place.
Scaffolding proteins and adaptors can recruit acetyltransferase complexes to specific substrates or chromatin regions, thereby enhancing local acetylation. This spatial regulation ensures targeted modification.
Crosstalk with Other Modifications
In simple terms: Other chemical marks can promote acetylation.
Phosphorylation, methylation, and ubiquitination can crosstalk with acetylation. For example, phosphorylation of an acetyltransferase can stimulate its activity, while ubiquitination may alter its stability, indirectly affecting acetylation levels.
Key Genes Involved in GO:2000758 positive regulation of peptidyl-lysine acetylation
The following genes and proteins are central to the positive regulation of peptidyl-lysine acetylation, based on current literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| GNAT family | Acetyltransferase enzymes | Directly add acetyl groups to lysine residues |
| HDACs | Deacetylases | Remove acetyl groups; their inhibition increases acetylation |
| Sirtuins | NAD+-dependent deacetylases | Regulate acetylation in response to metabolic state |
| ACAT | Acetyl-CoA acetyltransferase | Produces acetyl-CoA for acetylation |
| ACSS2 | Acetyl-CoA synthetase | Generates acetyl-CoA from acetate |
| p300/CBP | Histone acetyltransferases | Transcriptional coactivators; acetylate histones |
| PCAF | Histone acetyltransferase | Acetylates histones and non-histone proteins |
| GCN5 | Histone acetyltransferase | Part of SAGA complex; regulates transcription |
| TIP60 | Histone acetyltransferase | Involved in DNA repair and apoptosis |
| MOF | Histone acetyltransferase | Acetylates H4K16; role in chromatin |
| HDAC1 | Histone deacetylase | Removes acetyl groups; regulates gene expression |
| HDAC2 | Histone deacetylase | Involved in chromatin remodeling |
| HDAC3 | Histone deacetylase | Regulates metabolism and inflammation |
| SIRT1 | NAD+-dependent deacetylase | Links metabolism to acetylation |
| SIRT2 | NAD+-dependent deacetylase | Regulates cell cycle and aging |
| SIRT3 | Mitochondrial deacetylase | Controls metabolic enzymes |
| EP300 | Histone acetyltransferase | Mutated in cancers; key regulator |
| CREBBP | Histone acetyltransferase | Transcriptional coactivator; disease relevance |
How Is positive regulation of peptidyl-lysine acetylation Regulated?
The positive regulation of peptidyl-lysine acetylation is itself tightly regulated. Upstream signals such as growth factors, stress, and nutrient availability can activate signaling cascades (e.g., MAPK, PI3K/Akt) that converge on acetyltransferases and deacetylases. For instance, phosphorylation of acetyltransferases can enhance their catalytic activity, while metabolic cues influence acetyl-CoA levels. Additionally, feedback loops exist where acetylation of regulatory proteins alters their function, further modulating the process.
positive regulation of peptidyl-lysine acetylation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| EP300 | Cancer (colorectal, breast) | Knockout in cancer cell lines; xenograft models |
| CREBBP | Rubinstein-Taybi syndrome, cancer | Point mutation knock-in mice; patient-derived cells |
| HDAC2 | Neurodegeneration, cancer | Overexpression in neuronal cultures; conditional KO |
| SIRT1 | Metabolic disorders, aging | Knockout mice; metabolic phenotyping |
| GNAT family | Antibiotic resistance in E. coli | Knockout and point mutation in bacterial strains |
Cancer
Dysregulated lysine acetylation is a hallmark of many cancers. Overexpression or mutation of acetyltransferases (e.g., p300/CBP) and deacetylases (e.g., HDACs) can lead to aberrant gene expression, promoting tumorigenesis. Targeting positive regulators of acetylation is a promising therapeutic strategy.
Neurodegenerative Diseases
In Alzheimer's and Parkinson's diseases, altered acetylation of tau and alpha-synuclein contributes to protein aggregation and neurotoxicity. Positive regulation of acetylation may exacerbate pathology, making enzymes like HDACs and sirtuins drug targets.
Antibiotic Resistance
In Escherichia coli, lysine acetylation of metabolic enzymes and ribosomal proteins is associated with antibiotic resistance. Positive regulation of acetylation may enhance resistance by modifying drug targets or efflux pumps.
Metabolic Disorders
Acetylation regulates key metabolic enzymes, and its dysregulation is linked to diabetes and obesity. Positive regulators such as acetyl-CoA synthetases influence insulin sensitivity and lipid metabolism.
From positive regulation of peptidyl-lysine acetylation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X positively regulate acetylation? | CRISPR knockout of gene X followed by acetylation assays |
| Does a specific point mutation alter acetyltransferase activity? | CRISPR point mutation knock-in of the catalytic residue |
| Does overexpression of gene Y increase global acetylation? | CRISPR activation or cDNA overexpression |
| What is the interactome of an acetyltransferase? | Tagged knock-in (e.g., FLAG, HA) followed by mass spectrometry |
| How does acetylation affect antibiotic resistance? | Knockout of acetyltransferase in E. coli; MIC assays |
| Can a deacetylase inhibitor boost acetylation? | CRISPR knockout of deacetylase combined with drug treatment |
How to Study the positive regulation of peptidyl-lysine acetylation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Western blot with pan-acetyllysine | Global acetylation levels | Validation of genetic or drug perturbations |
| Acetylproteomics (LC-MS/MS) | Site-specific acetylation | Discovery of novel acetylation targets |
| ChIP-seq with H3K27ac | Genome-wide acetylation marks | Enhancer activity and transcription |
| Co-immunoprecipitation | Protein-protein interactions | Identifying acetyltransferase complexes |
| Enzymatic assays | Acetyltransferase/deacetylase activity | Kinetic characterization of enzymes |
| Metabolomics | Acetyl-CoA and related metabolites | Linking metabolism to acetylation |
| CRISPR screens | Genes regulating acetylation | Unbiased discovery of regulators |
| Flow cytometry | Acetylation in single cells | Heterogeneity studies |
Acetylation-specific Antibodies and Western Blot
Pan-acetyllysine antibodies enable detection of global acetylation changes. This method is widely used to validate positive regulation after genetic manipulation.
Mass Spectrometry-based Acetylproteomics
Quantitative mass spectrometry can identify and quantify acetylation sites on thousands of proteins, providing a systems-level view of positive regulation.
Chromatin Immunoprecipitation (ChIP)
ChIP with acetyl-specific antibodies (e.g., H3K27ac) reveals how positive regulation affects chromatin state and transcription.
Metabolic Flux Analysis
Measuring acetyl-CoA levels and flux through metabolic pathways helps determine how metabolism contributes to positive regulation of acetylation.
How CRISPR Can Be Used to Study GO:2000758 positive regulation of peptidyl-lysine acetylation
Knockout
CRISPR knockout of candidate genes (e.g., acetyltransferases or deacetylases) is used to determine their necessity in positive regulation. Loss-of-function studies can reveal whether a gene is required for baseline or induced acetylation.
Point Mutation
Introducing precise point mutations (e.g., catalytic dead versions) via CRISPR allows dissection of enzymatic activity versus scaffolding functions. This is critical for understanding mechanism.
Knock-in
Tagged knock-in (e.g., endogenous FLAG or GFP) enables visualization and purification of proteins under native regulation, facilitating interaction and localization studies.
Overexpression
CRISPR activation (CRISPRa) or cDNA overexpression can test sufficiency of a gene to drive positive regulation. This is useful for identifying gain-of-function phenotypes.
How EDITGENE Supports positive regulation of peptidyl-lysine acetylation Research
Researchers studying positive regulation of peptidyl-lysine acetylation-related genes often need to determine whether a candidate gene is causally involved in the process, and to dissect its precise mechanism of action. This requires robust, customizable cell models that allow for loss-of-function, gain-of-function, and precise mutation studies.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of peptidyl-lysine acetylation research.
Frequently Asked Questions About positive regulation of peptidyl-lysine acetylation
What is GO:2000758?
GO:2000758 is a Gene Ontology term for any process that activates or increases the frequency, rate or extent of peptidyl-lysine acetylation.
What genes are involved in positive regulation of peptidyl-lysine acetylation?
Key genes include acetyltransferases (e.g., EP300, CREBBP, GCN5), deacetylases (e.g., HDACs, SIRT1), and metabolic enzymes like ACSS2.
How does lysine acetylation affect protein function?
Acetylation neutralizes lysine's positive charge, altering protein stability, interactions, and enzymatic activity.
What diseases are linked to dysregulated lysine acetylation?
Cancer, neurodegenerative diseases, metabolic disorders, and antibiotic resistance in bacteria.
What methods are used to study positive regulation of acetylation?
Western blot with pan-acetyllysine antibodies, mass spectrometry, ChIP-seq, and CRISPR screens.
Can CRISPR be used to study acetylation regulators?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are powerful tools for dissecting regulatory mechanisms.
What is the role of acetyl-CoA in acetylation?
Acetyl-CoA is the acetyl group donor; its availability directly influences acetylation levels.
How is acetylation regulated by deacetylases?
Deacetylases remove acetyl groups; their inhibition or downregulation increases net acetylation.
What is the significance of acetylation in antibiotic resistance?
In E. coli, acetylation of metabolic enzymes and ribosomal proteins contributes to antibiotic resistance.
How can EDITGENE help my acetylation research?
EDITGENE offers custom CRISPR cell models, library screening, and bioinformatics to study positive regulation of acetylation.
Conclusion
Positive regulation of peptidyl-lysine acetylation (GO:2000758) is a fundamental biological process with far-reaching implications for cellular function and disease. Understanding its mechanisms, key genes, and regulatory networks is essential for developing targeted therapies. Leveraging advanced CRISPR technologies and multi-omics approaches will continue to illuminate this dynamic field.
References
- 1. Fang Z et al.. 2022. Potential Role of Lysine Acetylation in Antibiotic Resistance of Escherichia coli.. mSystems 7(6):e0064922 PMID: 36286553
